Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / VIR - GlaxoSmithKline: 4.57% Dividend Yield And Cure For COVID-19 And HIV

VIR - GlaxoSmithKline: 4.57% Dividend Yield And Cure For COVID-19 And HIV

Vir Biotechnology Inc.
  • GlaxoSmithKline is one of the eight largest pharmaceutical companies in the world.
  • The company's revenue continues to grow QoQ with a 9.3% increase in Q3 2021 compared to Q2 2021. Vaccine sales were £2,174 million in Q3 2021, up 38.4% from Q2.
  • Sales of Sotrovimab for COVID-19 were £114 million in Q3 2021, up 612.5% from Q2 2021.
  • ViiV Healthcare, majority-owned by GlaxoSmithKline, wins litigation against Gilead Sciences over HIV drug.
  • The dividend yield is 4.57%, which is one of the largest in the pharmaceutical industry.

For further details see:

GlaxoSmithKline: 4.57% Dividend Yield And Cure For COVID-19 And HIV
Stock Information
Company Name: Vir Biotechnology Inc.
Stock Symbol: VIR
Market: NYSE
Website: vir.bio
Menu
VIR VIR Quote VIR Short VIR News VIR Articles VIR Message Board
Get VIR Alerts

News, Short Squeeze, Breakout and More Instantly...